Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runsen Jin

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Translational Lung Cancer Research|November 19, 2020
Interactions between the enhanced recovery after surgery pathway and risk factors for lung infections after pulmonary malignancy operationXianfei Zhang, Runsen Jin, Yuyan Zheng, et al.
Cancer Biology & Therapy|April 24, 2014
Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1Yingjun Quan, Runsen Jin, Ao Huang, et al.
Journal of Thoracic Disease|March 20, 2020
Robot-assisted thoracoscopic surgery for mediastinal masses: a single-institution experienceKai Chen, Xianfei Zhang, Runsen Jin, et al.
Frontiers in Immunology|July 26, 2023
A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancerYichao Han, Si-Yang Maggie Liu, Runsen Jin, et al.
Journal of Cell Science|May 16, 2014
The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4Runsen Jin, Wensheng Liu, Sharleen Menezes, et al.
Cancer Biology & Medicine|September 18, 2020
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancerRunsen Jin, Chengming Liu, Sufei Zheng, et al.
Cancer Letters|April 10, 2020
Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinomaRunsen Jin, Xinfeng Wang, Ruochuan Zang, et al.
Oncology Reports|September 6, 2012
In vivo distribution and antitumor effect of infused immune cells in a gastric cancer modelXiaohui Du, Runsen Jin, Ning Ning, et al.
Translational Lung Cancer Research|May 22, 2026
Accelerating tumor evolution and enhancing immunotherapy efficacy in lung adenocarcinoma based on EXO1 inhibitionXianfei Zhang, Liangjiao Yao, Zhengxin Yin, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 1, 2015
MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancerWenpeng Zhang, Tao Zhang, Runsen Jin, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Translational Lung Cancer Research|November 19, 2020
Interactions between the enhanced recovery after surgery pathway and risk factors for lung infections after pulmonary malignancy operationXianfei Zhang, Runsen Jin, Yuyan Zheng, et al.
Cancer Biology & Therapy|April 24, 2014
Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1Yingjun Quan, Runsen Jin, Ao Huang, et al.
Journal of Thoracic Disease|March 20, 2020
Robot-assisted thoracoscopic surgery for mediastinal masses: a single-institution experienceKai Chen, Xianfei Zhang, Runsen Jin, et al.
Frontiers in Immunology|July 26, 2023
A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancerYichao Han, Si-Yang Maggie Liu, Runsen Jin, et al.
Journal of Cell Science|May 16, 2014
The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4Runsen Jin, Wensheng Liu, Sharleen Menezes, et al.
Cancer Biology & Medicine|September 18, 2020
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancerRunsen Jin, Chengming Liu, Sufei Zheng, et al.
Cancer Letters|April 10, 2020
Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinomaRunsen Jin, Xinfeng Wang, Ruochuan Zang, et al.
Oncology Reports|September 6, 2012
In vivo distribution and antitumor effect of infused immune cells in a gastric cancer modelXiaohui Du, Runsen Jin, Ning Ning, et al.
Translational Lung Cancer Research|May 22, 2026
Accelerating tumor evolution and enhancing immunotherapy efficacy in lung adenocarcinoma based on EXO1 inhibitionXianfei Zhang, Liangjiao Yao, Zhengxin Yin, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 1, 2015
MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancerWenpeng Zhang, Tao Zhang, Runsen Jin, et al.
Pageof 6